X. Froger

A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice

B. Fervers, I. Ray-Coquard, G. Browman, 2002, British Journal of Cancer.

Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network.

I. Ray-Coquard, F. Chauvin, A. Lurkin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ondansetron Compared with Granisetron in the Prophylaxis of Cyclophosphamide-lnduced Emesis in Out-Patients: A Multicentre, Double-Blind, Double-Dummy, Randomised, Parallel-Group Study

J. Forster, L. Goedhals, X. Froger, 1995 .

[Breast metastases of an ovarian adenocarcinoma].

I. Treilleux, X. Froger, J. Roux, 2003, Annales de dermatologie et de venereologie.

Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Cancer Patients.

L. Goedhals, X. Froger, A. Gudgeon, 1995, Oncology.